Botulinum Toxin A Injections to the Upper Limbs in Children With Cerebral Palsy: Duration of Effect

被引:8
作者
Fattal-Valevski, Aviva [1 ]
Sagi, Liora [1 ]
Domenievitz, Dafna [1 ]
机构
[1] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Dana Childrens Hosp,Pediat Neurol Unit, IL-64239 Tel Aviv, Israel
关键词
botulinum toxin type A; upper limbs; duration of effect; CLINICAL-IMPLICATIONS; MANAGEMENT; TRIAL; DYSFUNCTION; THERAPY;
D O I
10.1177/0883073810376446
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We report our experience on the duration of effectiveness of botulinum toxin A injections to the upper extremities of children with cerebral palsy. A retrospective chart review was conducted on 30 consecutive patients (mean age, 9.9 +/- 5.0 years) with spastic hemiparesis and quadriparesis. They received 1 to 5 treatments, totaling 56 treatments for the entire cohort. The injected muscles were the pronator teres (50/56), flexor carpi radialis (39/56), biceps (38/56), flexor carpi ulnaris (35/56), opponens (21/56), and adductor pollicis (17/56). Children were assessed for muscle tone and classified according to the Manual Ability Classification System before and after treatment. Functional improvement was apparent after 42 of 56 treatments, and muscle tone decreased significantly (P < .001). The mean duration of the effect was 7.0 +/- 3.0 months. We conclude that the effect of botulinum toxin A to the upper limbs is retained for longer periods of time than those reported for lower limbs.
引用
收藏
页码:166 / 170
页数:5
相关论文
共 23 条
  • [1] Allergan Inc, 2010, BOTOXR ONABOTULINUMT
  • [2] Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury:: clinical implications
    Autti-Rämö, I
    Larsen, A
    Taimo, A
    von Wendt, L
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 : 136 - 144
  • [3] Boyd R, 1997, EUR J NEUROL, V4, pS15
  • [4] Management of upper limb dysfunction in children with cerebral palsy: a systematic review
    Boyd, RN
    Morris, ME
    Graham, HK
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 : 150 - 166
  • [5] Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy
    Boyd, RN
    Graham, HK
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 : S23 - S35
  • [6] Brin M F, 1997, Muscle Nerve Suppl, V6, pS208
  • [7] Corry IS, 1997, DEV MED CHILD NEUROL, V39, P185
  • [8] The Manual Ability Classification System (MACS) for children with cerebral palsy:: scale development and evidence of validity and reliability
    Eliasson, Ann-Christin
    Krumlinde-Sundholm, Lena
    Rosblad, Birgit
    Beckung, Eva
    Arner, Marianne
    Ohrvall, Ann-Marie
    Rosenbaum, Peter
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2006, 48 (07) : 549 - 554
  • [9] Long-term effect of repeated injections of botulinum toxin in children with cerebral palsy: a prospective study
    Fattal-Valevski, Aviva
    Domenievitz, Dafna
    Giladi, Nir
    Wientroub, Shlomo
    Hayek, Shlomo
    [J]. JOURNAL OF CHILDRENS ORTHOPAEDICS, 2008, 2 (01) : 29 - 35
  • [10] An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy
    Fehlings, D
    Rang, M
    Glazier, J
    Steele, C
    [J]. JOURNAL OF PEDIATRICS, 2000, 137 (03) : 331 - 337